Lineage Cell Therapeutics Inc (LTS:0HNF)
$ 1.07 0 (0%) Market Cap: 137.84 Mil Enterprise Value: 100.87 Mil PE Ratio: 0 PB Ratio: 2.55 GF Score: 60/100

Lineage Cell Therapeutics, Inc. - Special Call Transcript

Jun 08, 2020 / 08:30PM GMT
Operator

Good day, ladies and gentlemen. Thank you for standing by. Welcome to the Lineage Cell Therapeutics Conference Call. (Operator Instructions) An audio webcast of this call is available on the Investors section of Lineage's website at www.lineagecell.com. (Operator Instructions) As a reminder, today's call is being recorded. A question-and-answer session will follow the formal presentation. All questions must be submitted electronically.

On the left-hand side of your screen, you will see a question mark icon. To submit a question, click the question mark, type your question in the box and click send.

I will now turn over the call to Brian Culley, Chief Executive Officer of Lineage Cell Therapeutics.

Brian M. Culley
Lineage Cell Therapeutics, Inc. - CEO, President & Director

Well, thank you, everyone, and welcome to a very special event we have today. A therapeutic expert discussion where we will be reviewing a finding of retinal tissue restoration in a patient with dry-AMD

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot